Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Database and Biobank of Patients With Gynecologic Neoplasms

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01267851
Recruitment Status : Recruiting
First Posted : December 29, 2010
Last Update Posted : July 19, 2019
Sponsor:
Collaborators:
Zhejiang University
Hunan Province Tumor Hospital
Guangxi Medical University
First Affiliated Hospital Xi'an Jiaotong University
West China Second University Hospital
Obstetrics & Gynecology Hospital of Fudan University
Shanghai First Maternity and Infant Hospital
Peking University People's Hospital
The Central Hospital of Wuhan
Information provided by (Responsible Party):
Ding Ma, Huazhong University of Science and Technology

Brief Summary:
The database and biobank establishment started in 1997 in our institute. However, the sample size was too small with respect to our clinical and fundamental scientific research's requirement. Thus the Chinese gynecological oncology study (GOS) group was established to create a large multicentre database and biobank of patients with gynecologic diseases.

Condition or disease
Cervical Cancer Ovarian Cancer Endometrial Cancer Choriocarcinoma Uterine Myoma Endometriosis

Detailed Description:

The database contains clinical and epidemiologic information about patients with gynecologic neoplasms, such as cervical carcinoma, ovarian carcinoma, etc. With the data gathered from this database, the investigators could further demonstrate the etiology, risk factor, clinical treatment, and other aspects of the complicated gynecologic diseases. The cervical cancer database v1.10 including more than 10,000 cases and more than 200 variables has been established.

The biobank collects blood, fluids, tissue samples, and related clinical data from consenting patients with gynecologic neoplasms, such as cervical cancer, ovarian cancer, endometrial cancer, choriocarcinoma, uterine myoma, endometriosis. Besides, blood samples of population-based healthy people with informed consent are also collected.


Layout table for study information
Study Type : Observational
Estimated Enrollment : 1600000 participants
Observational Model: Other
Time Perspective: Retrospective
Official Title: A Large Multicentre Clinical Database and Biobank of Patients With Gynecologic Neoplasms
Actual Study Start Date : January 1, 2010
Estimated Primary Completion Date : December 30, 2019
Estimated Study Completion Date : December 30, 2020






Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
gynecologic diseases, such as cervical cancer, ovarian cancer, endometrial cancer, choriocarcinoma, uterine myoma, endometriosis, as well as part of population-based healthy women
Criteria

Inclusion Criteria:

  • patients with informed consent;
  • patients with gynecologic diseases;
  • patients with intact clinical and pathological information

Exclusion Criteria:

  • not included in the inclusion criteria

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01267851


Contacts
Layout table for location contacts
Contact: Ma Ding, M.D. 86-27-8362681 dma@tjh.tjmu.edu.cn

Locations
Layout table for location information
China, Hubei
Tongji Hospital of HUST Recruiting
Wuhan, Hubei, China
Contact: Ma Ding, M.D.    86-27-8362681    dma@tjh.tjmu.edu.cn   
Sponsors and Collaborators
Huazhong University of Science and Technology
Zhejiang University
Hunan Province Tumor Hospital
Guangxi Medical University
First Affiliated Hospital Xi'an Jiaotong University
West China Second University Hospital
Obstetrics & Gynecology Hospital of Fudan University
Shanghai First Maternity and Infant Hospital
Peking University People's Hospital
The Central Hospital of Wuhan

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Ding Ma, Director of the department of Obstetrics and Gynecology, Tongji Hospital, Huazhong University of Science and Technology
ClinicalTrials.gov Identifier: NCT01267851     History of Changes
Other Study ID Numbers: GM2010-06-02
First Posted: December 29, 2010    Key Record Dates
Last Update Posted: July 19, 2019
Last Verified: July 2019

Keywords provided by Ding Ma, Huazhong University of Science and Technology:
gynecologic disease

Additional relevant MeSH terms:
Layout table for MeSH terms
Endometriosis
Neoplasms
Uterine Cervical Neoplasms
Endometrial Neoplasms
Choriocarcinoma
Leiomyoma
Myofibroma
Genital Neoplasms, Female
Uterine Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female
Trophoblastic Neoplasms
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Adenocarcinoma
Carcinoma
Neoplasms, Glandular and Epithelial
Pregnancy Complications, Neoplastic
Pregnancy Complications
Neoplasms, Muscle Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms, Connective Tissue
Connective Tissue Diseases